About Seizure Disorders

neuroAgility for seizure disor­ders

A seizure occurs when the brain’s elec­trical signaling discharges abnor­mally and exces­sively. The best known type of seizure is the gener­al­ized or tonic-clonic seizure which involves whole body convul­sions and tempo­rary loss of conscious­ness. Other seizures are more limited in scope and may cause brief distur­bances of move­ment, conscious­ness, emotion, sensa­tion or tempo­rary inability to speak. These are known as partial or partial complex seizures. The symp­toms of a seizure corre­late directly with the area of the brain that is affected; a “partial seizure” usually affects only one side of the brain, while a “gener­al­ized seizure” involves both sides of the brain. Seizures may be caused or exac­er­bated by many medical condi­tions including congen­ital brain disor­ders, meta­bolic imbal­ances, and trau­matic brain injury.

A new onset or first seizure of any magni­tude warrants imme­diate medical atten­tion. If an indi­vidual expe­ri­ences repeated seizures over time, s/he may be diag­nosed with epilepsy. Treat­ments for seizure disor­ders include phar­ma­ceu­tical medica­tion, dietary modi­fi­ca­tion, lifestyle adjust­ment, and neurotherapy. All persons with repeated seizures or epilepsy should be under the care of a physi­cian with special compe­tency in this area, usually a neurol­o­gist.

“It is particularly noteworthy that these results have been achieved in an extremely difficult subgroup of epilepsy patients, those with poorly controlled seizures who had proven unresponsive to pharmacological treatment.” - Sterman Egner


The first study of neurotherapy in epilepsy was reported in 1972 by Sterman & Friar (1). Since then, a number of clin­ical studies from different labo­ra­to­ries have reported data on the effi­cacy of neuro­feed­back training in epileptic patients. In their review of this liter­a­ture, Sterman and Egner (2) remark that “It is partic­u­larly note­worthy that these results have been achieved in an extremely diffi­cult subgroup of epilepsy patients, those with poorly controlled seizures who had proven unre­spon­sive to phar­ma­co­log­ical treat­ment.”

Neurotherapy is an effec­tive, safe, and nonin­va­sive way to improve inef­fi­cien­cies and resolve imbal­ances in brain elec­trical activity. As such it may be useful in improving quality of life and func­tioning in epilepsy patients who have not achieved satis­fac­tory seizure control at well toler­ated levels of anti­con­vul­sant medica­tion.

neuroAgility offers a state of the art program begin­ning with qEEG brain mapping to iden­tify dysfunc­tional brain elec­trical patterns. Neurotherapy may then be employed to re-balance and opti­mize these patterns. Patients may note impor­tant improve­ment in quality of life and cogni­tive func­tioning (3). At neuroAgility, our expec­ta­tion and require­ment is that all clients with epilepsy or other seizure disor­ders be under the care of their own neurol­o­gist or other physi­cian with exper­tise in epilepsy.

1- Sterman, M.B., Friar, L. (1972). Suppres­sion of seizures in an epileptic following senso­ri­motor EEG feed­back training. Elec­troen­cephalogr. Clin. Neuro­physiol. 33, 89–95.

2- M. Barry Sterman and Tobias Egner. Foun­da­tion and Prac­tice of Neuro­feed­back for the Treat­ment of Epilepsy. Applied Psychophys­i­ology and Biofeed­back, Volume 31, Number 1, 21–35, DOI: 10.1007/s10484-006‑9002‑x

3‑Strehl,Leins,Goth, Klinger, Hinterberger,Birbaumer, Self-regu­la­tion of Slow Cortical Poten­tials: A New Treat­ment for Chil­dren With Atten­tion-Deficit/Hy­per­ac­tivity Disorder Pedi­atrics Vol. 118 No. 5 November 1, 2006 pp. e1530 ‑e1540